DE000003490583 Analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung

Settings

Stemming

Single Family Member

Include NPL

Office

Germany

Application Number 3490583

Application Date 12.12.1984

Publication Number 000003490583

Publication Date 03.04.1986

Publication Kind T5

IPC

CPC

Applicants Richardson-Vicks Inc., Wilton, Conn., US

Inventors Laska, Eugene M., Larchmont, N.Y., US
Siegel, Carole E., Mamaroneck, N.Y., US
Sunshine, Abraham, New York, N.Y., US

Priority Data 06560576 12.12.1983 US

Title

(DE) Analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
D	HETEROCYCLIC COMPOUNDS
473	Heterocyclic compounds containing purine ring systems
02	with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6
04	two oxygen atoms

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
D	HETEROCYCLIC COMPOUNDS
473	Heterocyclic compounds containing purine ring systems
02	with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6
04	two oxygen atoms
06	with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
53	having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
185	Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19	Carboxylic acids, e.g. valproic acid

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495	having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505	Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519	ortho- or peri-condensed with heterocyclic rings
52	Purines, e.g. adenine